G. Steven Burrill

An introduction to Burrill Venture Capital

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech takes a beating in market meltdown October 01, 2008 | Press Release

Biotech outperforms market in May June 02, 2008 | Press Release

Biotech Treads Water in April May 01, 2008 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

 


Chromatin is developing plant mini-chromosome technology that will enable entire chromosomes to be designed and incorporated into plant cells. The mini-chromosomes will allow introduction of new genes, stacks of genes and whole metabolic pathways without disrupting the plant's own genome. These precision genetics can accelerate product development and launch. The Company intends to design and market proprietary mini-chromosomes that confer commercially valuable traits in plants.

Website: http://www.chromatininc.com